Materials and Methods
All solvents and reagents were used as supplied from commercial sources. Analytical thin-layer chromatography was performed using Kieselgel F254 0.2 mm (Merck) silica plates with visualization by ultraviolet irradiation (254 nm) followed by staining with ninhydrin. Flash chromatography was performed using Kieselgel S63-100 μm (Riedel-de-Hahn) silica gel. All solvent compositions reported are on a volume/volume (v/v) basis. 
Synthesis of
To an ice-cooled solution of Fmoc-Lys-OH 5 (1.0 g, 2.82 mmol, 1 equiv) in 1 M aqueous K 2 CO 3 (7 ml) and 1,4-dioxane (10 ml) was added NsCl (0.74 g, 3.36 mmol,1.2 equiv) as a solution in dioxane (5 ml). The reaction was allowed to warm to rt and stirred for 2 h. The reaction mixture was partitioned between ethyl acetate (25 ml) and H 2 O (25 ml) and the layers separated. The aqueous layer was extracted with ethyl acetate (2 x 20 ml) and the combined extracts washed with brine, dried over MgSO 4 , filtered and concentrated under reduced pressure. Purification by flash chromatography (100% ethyl acetate) afforded the title compound as a white solid (1.35 g, 90% yield). Spectroscopic data were in good agreement with those previously reported. 156.2, 147.8, 143.8, 140.7, 134.0, 132.8, 132.6, 129.4, 127.7, 127.1, 125.3, 124.4, 120.1, 65.6, 53.7, 46.7, 42.5, 30.2, 28.8, 22 .7.
Peptide Synthesis

Automated SPPS
Standard SPPS was performed via the Fmoc strategy on aminomethyl resin equipped with a Rink Amide linker using a Biotage Alstra peptide synthesiser (Uppsala, Sweden) on 0.1 mmol scale. The 
Alkylation with tert-butyl bromoacetate
Resin-bound peptide 10 or 12 (0.1 mmol, 1 equiv) was swollen in dichloromethane (30 min), then in DMF (10 min), and drained. A solution of tert-butyl bromoacetate (70 μl, 0.5 mmol, 5 equiv) with DIPEA (175 μl, 1 mmol, 10 equiv) in DMF (5 ml) was added in one portion and the reaction mixture shaken overnight at rt to afford peptides 11 or 13 respectively, which were drained and washed with DMF.
Ns Deprotection
Resin-bound peptide 8 or 11 (0.1 mmol, 1 equiv) was swollen in dichloromethane (30 min), then in DMF (10 min) and filtered. A solution of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (90 μl, 0.6 mmol, 6 equiv) and 2-mercaptoethanol (42 μl, 0.6 mmol, 6 equiv) in DMF (5 ml) was added in one portion and the mixture shaken for 15 min, drained, and washed with DMF.
Peptide Purification
Following completion of syntheses, the peptides were released from resin with concomitant removal of the remaining side-chain protecting groups by treatment with trifluoroacetic acid (TFA)/triisopropyl silane (TIS)/H 2 O (38:1:1, 5 ml) at rt for 2 h. The crude peptides were precipitated with cold diethyl ether, isolated by centrifugation, washed in cold diethyl ether, dissolved in 1:1 acetonitrile/H 2 O containing 0.1% TFA and lyophilized. The peptides were analysed for purity by liquid chromatography mass spectrometry (LCMS) (Agilent 1120 compact LC system equipped with Agilent 6120 Quadrupole MS and a UV detector at 214 nm) using a Zorbax C3 column (3.5 μ; 3 x 150 mm; Agilent) at 0.3 ml/min using a linear gradient. The solvent system used was A (0.1% formic acid in H 2 O) and B (0.1% formic acid in acetonitrile). Purification of crude peptides was performed by semipreparative high-performance liquid chromatography (HPLC) (Dionex Ultimate 3000 equipped with a 4 channel UV detector) at 210, 230, 254, and 280 nm using a Gemini C18 column (10 μ; 250 x 10 mm; Phenomenex) at 5 ml/min using a shallow linear gradient. The solvent system used was A (0.1% TFA in H 2 O) and B (0.1% TFA in acetonitrile). The resulting purified peptides were analysed by the LCMS system used for crude peptide analysis. The purities were extrapolated from integrating the peaks corresponding to peptide 1 (13.1 min) and to peptide 2 (12.7 min) ( 
